id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02339948
|
42:71:treatment
|
Tissue for diagnosis must be obtained by transrectal ultrasound biopsy
| 2
|
[
"Tissue",
"for",
"diagnosis",
"must",
"be",
"obtained",
"by",
"transrectal",
"ultrasound",
"biopsy"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01978509
|
1:16:chronic_disease
|
Toxic megacolon
| 2
|
[
"Toxic",
"megacolon"
] |
[
2,
2
] |
NCT02201992
|
41:63:treatment
|
Patients may not be receiving any other investigational agents while on study
| 2
|
[
"Patients",
"may",
"not",
"be",
"receiving",
"any",
"other",
"investigational",
"agents",
"while",
"on",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02091999
|
8:29:chronic_disease
|
Active Hepatitis C infection
| 2
|
[
"Active",
"Hepatitis",
"C",
"infection"
] |
[
0,
2,
2,
2
] |
NCT01639508
|
1:7:chronic_disease,19:22:chronic_disease,33:41:chronic_disease,49:70:chronic_disease
|
stroke (including TIA, or other ischemic event) myocardial infarction
| 2
|
[
"stroke",
"(",
"including",
"TIA",
",",
"or",
"other",
"ischemic",
"event",
")",
"myocardial",
"infarction"
] |
[
2,
0,
0,
2,
0,
0,
0,
2,
0,
0,
2,
2
] |
NCT02465060
|
14:40:treatment
|
Stopping the anticoagulation for biopsy should be per site standard operating procedure (SOP)
| 2
|
[
"Stopping",
"the",
"anticoagulation",
"for",
"biopsy",
"should",
"be",
"per",
"site",
"standard",
"operating",
"procedure",
"(",
"SOP",
")"
] |
[
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02947373
|
20:34:treatment
|
Patients receiving active therapy on an investigational trial at the time of enrollment should consult with the study chair regarding potential interactions with other study agents
| 2
|
[
"Patients",
"receiving",
"active",
"therapy",
"on",
"an",
"investigational",
"trial",
"at",
"the",
"time",
"of",
"enrollment",
"should",
"consult",
"with",
"the",
"study",
"chair",
"regarding",
"potential",
"interactions",
"with",
"other",
"study",
"agents"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01684397
|
33:39:cancer,
|
Subjects diagnosed with another cancer in the past 3 years
| 2
|
[
"Subjects",
"diagnosed",
"with",
"another",
"cancer",
"in",
"the",
"past",
"3",
"years"
] |
[
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02498535
|
10:34:treatment,43:56:treatment,106:115:treatment,117:127:treatment,129:139:treatment,143:150:treatment
|
Use of a nitric oxide donor agent such as nitroglycerin or drugs known to increase methemoglobin such as lidocaine, prilocaine, benzocaine or dapsone at screening
| 2
|
[
"Use",
"of",
"a",
"nitric",
"oxide",
"donor",
"agent",
"such",
"as",
"nitroglycerin",
"or",
"drugs",
"known",
"to",
"increase",
"methemoglobin",
"such",
"as",
"lidocaine",
",",
"prilocaine",
",",
"benzocaine",
"or",
"dapsone",
"at",
"screening"
] |
[
0,
0,
0,
1,
1,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0
] |
NCT02359097
|
42:57:treatment
|
Subjects who have a contraindication for 3 tesla (T) MRI
| 2
|
[
"Subjects",
"who",
"have",
"a",
"contraindication",
"for",
"3",
"tesla",
"(",
"T",
")",
"MRI"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT02570854
|
11:23:treatment,
|
Receiving hemodialysis at least 2 times per week
| 2
|
[
"Receiving",
"hemodialysis",
"at",
"least",
"2",
"times",
"per",
"week"
] |
[
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02950337
|
1:22:chronic_disease
|
Chronic heart disease
| 2
|
[
"Chronic",
"heart",
"disease"
] |
[
2,
2,
2
] |
NCT00967785
|
43:52:chronic_disease
|
Absence of a documented history of severe infection
| 2
|
[
"Absence",
"of",
"a",
"documented",
"history",
"of",
"severe",
"infection"
] |
[
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02091999
|
4:18:treatment,22:43:treatment,,92:110:treatment
|
no red blood cell or platelet transfusions are allowed within 14 days of the first dose of enfortumab vedotin
| 2
|
[
"no",
"red",
"blood",
"cell",
"or",
"platelet",
"transfusions",
"are",
"allowed",
"within",
"14",
"days",
"of",
"the",
"first",
"dose",
"of",
"enfortumab",
"vedotin"
] |
[
0,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02680535
|
1:19:chronic_disease
|
metastatic disease
| 2
|
[
"metastatic",
"disease"
] |
[
2,
2
] |
NCT00739362
|
1:28:chronic_disease,40:77:chronic_disease,154:186:chronic_disease
|
Chronic pulmonary disorders, including chronic obstructive pulmonary disease that would limit ability to follow the protocol (investigator judgment) and obstructive sleep apnea syndrome
| 2
|
[
"Chronic",
"pulmonary",
"disorders",
",",
"including",
"chronic",
"obstructive",
"pulmonary",
"disease",
"that",
"would",
"limit",
"ability",
"to",
"follow",
"the",
"protocol",
"(",
"investigator",
"judgment",
")",
"and",
"obstructive",
"sleep",
"apnea",
"syndrome"
] |
[
2,
2,
2,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02563678
|
23:49:treatment
|
Medical clearance for hyperbaric oxygen exposure
| 2
|
[
"Medical",
"clearance",
"for",
"hyperbaric",
"oxygen",
"exposure"
] |
[
0,
0,
0,
1,
1,
1
] |
NCT02339233
|
1:14:chronic_disease,,
|
severe anemia (Hgb<8 g/dL)
| 2
|
[
"severe",
"anemia",
"(",
"Hgb",
"<",
"8",
"g/dL",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02089607
|
26:66:treatment,115:155:treatment,166:191:treatment,217:232:treatment,254:269:treatment,317:357:treatment,378:395:chronic_disease,397:425:chronic_disease
|
Participation in another investigational clinical or device trial, with the exception of participation in another investigational endovascular stent-graft protocol, percutaneous aortic valve protocol, or concomitant clinical trials designed to evaluate medical therapy strategies to reduce perioperative risk during fenestrated-branched endovascular repair, including risks of renal dysfunction, contrast-induced nephropathy, neurologic, spinal cord or cardiac complications, and/or use of advanced imaging to reduce radiation exposure during implantation of these devices
| 2
|
[
"Participation",
"in",
"another",
"investigational",
"clinical",
"or",
"device",
"trial",
",",
"with",
"the",
"exception",
"of",
"participation",
"in",
"another",
"investigational",
"endovascular",
"stent-graft",
"protocol",
",",
"percutaneous",
"aortic",
"valve",
"protocol",
",",
"or",
"concomitant",
"clinical",
"trials",
"designed",
"to",
"evaluate",
"medical",
"therapy",
"strategies",
"to",
"reduce",
"perioperative",
"risk",
"during",
"fenestrated-branched",
"endovascular",
"repair",
",",
"including",
"risks",
"of",
"renal",
"dysfunction",
",",
"contrast-induced",
"nephropathy",
",",
"neurologic",
",",
"spinal",
"cord",
"or",
"cardiac",
"complications",
",",
"and/or",
"use",
"of",
"advanced",
"imaging",
"to",
"reduce",
"radiation",
"exposure",
"during",
"implantation",
"of",
"these",
"devices"
] |
[
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02484404
|
38:53:cancer,57:82:treatment,87:113:cancer
|
Patients who have had progression of prostate cancer on prior docetaxel treatment for castrate sensitive disease are ineligible
| 2
|
[
"Patients",
"who",
"have",
"had",
"progression",
"of",
"prostate",
"cancer",
"on",
"prior",
"docetaxel",
"treatment",
"for",
"castrate",
"sensitive",
"disease",
"are",
"ineligible"
] |
[
0,
0,
0,
0,
0,
0,
3,
3,
0,
1,
1,
1,
0,
3,
3,
3,
0,
0
] |
NCT01787682
|
22:40:chronic_disease,51:58:chronic_disease,62:76:chronic_disease
|
History of untreated metabolic diseases including hepatic or renal disorder
| 2
|
[
"History",
"of",
"untreated",
"metabolic",
"diseases",
"including",
"hepatic",
"or",
"renal",
"disorder"
] |
[
0,
0,
0,
2,
2,
0,
2,
0,
2,
2
] |
NCT03158974
|
1:35:treatment
|
Oral or parenteral corticosteroids
| 2
|
[
"Oral",
"or",
"parenteral",
"corticosteroids"
] |
[
1,
1,
1,
1
] |
NCT01865162
|
12:33:cancer
|
History of non-glioma malignancy
| 2
|
[
"History",
"of",
"non-glioma",
"malignancy"
] |
[
0,
0,
3,
3
] |
NCT02169739
|
11:17:chronic_disease,,
|
Disabling stroke (Rankin Scale ≥4)
| 2
|
[
"Disabling",
"stroke",
"(",
"Rankin",
"Scale",
"≥4",
")"
] |
[
0,
2,
0,
0,
0,
0,
0
] |
NCT02323191
|
39:59:chronic_disease,161:183:chronic_disease,193:251:chronic_disease,253:274:chronic_disease,,310:321:chronic_disease,326:341:chronic_disease,346:363:chronic_disease,375:404:chronic_disease,432:444:chronic_disease
|
Evidence of significant, uncontrolled concomitant diseases, which could affect compliance with the protocol or interpretation of results, including significant cardiovascular disease (such as New York Heart Association Class III or IV cardiac disease, myocardial infarction within the last 6 months, unstable arrhythmias, or unstable angina) or pulmonary disease (including obstructive pulmonary disease and history of symptomatic bronchospasm)
| 2
|
[
"Evidence",
"of",
"significant",
",",
"uncontrolled",
"concomitant",
"diseases",
",",
"which",
"could",
"affect",
"compliance",
"with",
"the",
"protocol",
"or",
"interpretation",
"of",
"results",
",",
"including",
"significant",
"cardiovascular",
"disease",
"(",
"such",
"as",
"New",
"York",
"Heart",
"Association",
"Class",
"III",
"or",
"IV",
"cardiac",
"disease",
",",
"myocardial",
"infarction",
"within",
"the",
"last",
"6",
"months",
",",
"unstable",
"arrhythmias",
",",
"or",
"unstable",
"angina",
")",
"or",
"pulmonary",
"disease",
"(",
"including",
"obstructive",
"pulmonary",
"disease",
"and",
"history",
"of",
"symptomatic",
"bronchospasm",
")"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
2,
0
] |
NCT02414269
|
15:18:chronic_disease,,
|
Patients with MPD aged ≥18 years
| 2
|
[
"Patients",
"with",
"MPD",
"aged",
"≥18",
"years"
] |
[
0,
0,
2,
0,
0,
0
] |
NCT02145260
|
1:11:chronic_disease,
|
Chronic HD (>90 days)
| 2
|
[
"Chronic",
"HD",
"(",
">",
"90",
"days",
")"
] |
[
2,
2,
0,
0,
0,
0,
0
] |
NCT02214550
|
20:52:cancer
|
presence of active pelvic or abdominal malignancies (primary or metastatic)
| 2
|
[
"presence",
"of",
"active",
"pelvic",
"or",
"abdominal",
"malignancies",
"(",
"primary",
"or",
"metastatic",
")"
] |
[
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0
] |
NCT02336451
|
13:38:chronic_disease,42:52:chronic_disease,100:109:treatment,117:136:chronic_disease,182:204:chronic_disease
|
Patient has impairment of GI function or GI disease that may significantly alter the absorption of ceritinib (e.g., ulcerative diseases, uncontrolled nausea, vomiting, diarrhea, or malabsorption syndrome)
| 2
|
[
"Patient",
"has",
"impairment",
"of",
"GI",
"function",
"or",
"GI",
"disease",
"that",
"may",
"significantly",
"alter",
"the",
"absorption",
"of",
"ceritinib",
"(",
"e.g.",
",",
"ulcerative",
"diseases",
",",
"uncontrolled",
"nausea",
",",
"vomiting",
",",
"diarrhea",
",",
"or",
"malabsorption",
"syndrome",
")"
] |
[
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT02464878
|
20:35:chronic_disease
|
Severe co-existing cardiac disease
| 2
|
[
"Severe",
"co-existing",
"cardiac",
"disease"
] |
[
0,
0,
2,
2
] |
NCT02145351
|
35:37:chronic_disease
|
Hospitalization for decompensated HF
| 2
|
[
"Hospitalization",
"for",
"decompensated",
"HF"
] |
[
0,
0,
0,
2
] |
NCT02852239
|
33:48:chronic_disease
|
History or current diagnosis of cardiac disease indicating significant risk such as uncontrolled
| 2
|
[
"History",
"or",
"current",
"diagnosis",
"of",
"cardiac",
"disease",
"indicating",
"significant",
"risk",
"such",
"as",
"uncontrolled"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02418195
|
1:4:chronic_disease,26:41:chronic_disease,51:68:chronic_disease
|
MDD Participants without Suicide Attempt, without SUicidal Ideation
| 2
|
[
"MDD",
"Participants",
"without",
"Suicide",
"Attempt",
",",
"without",
"SUicidal",
"Ideation"
] |
[
2,
0,
0,
2,
2,
0,
0,
2,
2
] |
NCT00338377
|
15:24:treatment,97:111:treatment,,165:180:treatment,192:213:treatment,217:242:treatment,,292:307:treatment,,376:379:cancer
|
Patients with VP shunts must have VP shunts with on/off valves and must be expected to tolerate VP shunt valve off for more than 6 hours Patients who have received CNS irradiation, including whole brain radiation or stereotactic radiosurgery, are eligible, if they are at least 1 weeks post CNS-irradiation (Cohort D)Patients who are currently being treated with IT IL-2 for LMD are eligible. No wash out period is required. (Cohort D)
| 2
|
[
"Patients",
"with",
"VP",
"shunts",
"must",
"have",
"VP",
"shunts",
"with",
"on/off",
"valves",
"and",
"must",
"be",
"expected",
"to",
"tolerate",
"VP",
"shunt",
"valve",
"off",
"for",
"more",
"than",
"6",
"hours",
"Patients",
"who",
"have",
"received",
"CNS",
"irradiation",
",",
"including",
"whole",
"brain",
"radiation",
"or",
"stereotactic",
"radiosurgery",
",",
"are",
"eligible",
",",
"if",
"they",
"are",
"at",
"least",
"1",
"weeks",
"post",
"CNS-irradiation",
"(",
"Cohort",
"D",
")",
"Patients",
"who",
"are",
"currently",
"being",
"treated",
"with",
"IT",
"IL-2",
"for",
"LMD",
"are",
"eligible",
".",
"No",
"wash",
"out",
"period",
"is",
"required",
".",
"(",
"Cohort",
"D",
")"
] |
[
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02466750
|
32:39:treatment,43:66:treatment,,85:100:treatment
|
Have administration of another vaccine or investigational product within 28 days of WEE vaccination
| 2
|
[
"Have",
"administration",
"of",
"another",
"vaccine",
"or",
"investigational",
"product",
"within",
"28",
"days",
"of",
"WEE",
"vaccination"
] |
[
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
1,
1
] |
NCT02698722
|
1:17:chronic_disease
|
Stage 4 or 5 CKD
| 2
|
[
"Stage",
"4",
"or",
"5",
"CKD"
] |
[
2,
2,
2,
2,
2
] |
NCT01894061
|
15:37:cancer
|
Patients with leptomeningeal disease
| 2
|
[
"Patients",
"with",
"leptomeningeal",
"disease"
] |
[
0,
0,
3,
3
] |
NCT02437851
|
17:22:cancer,26:39:chronic_disease,43:52:chronic_disease
|
Concurrent anal canal or perianal HSIL or condyloma that in the judgment of the clinician cannot be cleared or can only be cleared with undue morbidity to the patient
| 2
|
[
"Concurrent",
"anal",
"canal",
"or",
"perianal",
"HSIL",
"or",
"condyloma",
"that",
"in",
"the",
"judgment",
"of",
"the",
"clinician",
"can",
"not",
"be",
"cleared",
"or",
"can",
"only",
"be",
"cleared",
"with",
"undue",
"morbidity",
"to",
"the",
"patient"
] |
[
0,
0,
3,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02412540
|
1:28:chronic_disease,64:67:treatment,91:94:chronic_disease,106:139:chronic_disease,
|
Active psychiatric disorder that would prevent eligibility for WLS or impede adherence to CLI, including clinically significant depression (hospitalization or suicidal ideation) in past 12 months
| 2
|
[
"Active",
"psychiatric",
"disorder",
"that",
"would",
"prevent",
"eligibility",
"for",
"WLS",
"or",
"impede",
"adherence",
"to",
"CLI",
",",
"including",
"clinically",
"significant",
"depression",
"(",
"hospitalization",
"or",
"suicidal",
"ideation",
")",
"in",
"past",
"12",
"months"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02833207
|
26:39:chronic_disease
|
Self-reported history of renal disease
| 2
|
[
"Self-reported",
"history",
"of",
"renal",
"disease"
] |
[
0,
0,
0,
2,
2
] |
NCT02755896
|
29:60:cancer,68:88:treatment,114:151:cancer
|
Presence of a proportion of Ductal Carcinoma in-situ (DCIS) in the core biopsy specimen which is compatible with extensive intraductal component (EIC)
| 2
|
[
"Presence",
"of",
"a",
"proportion",
"of",
"Ductal",
"Carcinoma",
"in-situ",
"(",
"DCIS",
")",
"in",
"the",
"core",
"biopsy",
"specimen",
"which",
"is",
"compatible",
"with",
"extensive",
"intraductal",
"component",
"(",
"EIC",
")"
] |
[
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0
] |
NCT03060772
|
12:26:cancer
|
History of bladder cancer
| 2
|
[
"History",
"of",
"bladder",
"cancer"
] |
[
0,
0,
3,
3
] |
NCT02905370
|
1:22:treatment
|
Post-op bowel surgery
| 2
|
[
"Post-op",
"bowel",
"surgery"
] |
[
1,
1,
1
] |
NCT00967577
|
28:47:allergy_name
|
Prior allergic reaction to Gadolinium contrast
| 2
|
[
"Prior",
"allergic",
"reaction",
"to",
"Gadolinium",
"contrast"
] |
[
0,
0,
0,
0,
4,
4
] |
NCT02131389
|
19:41:chronic_disease,48:68:chronic_disease,70:99:chronic_disease,101:120:chronic_disease,122:150:chronic_disease
|
Is suffering from inflammatory arthritis (e.g. rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, etc.)
| 2
|
[
"Is",
"suffering",
"from",
"inflammatory",
"arthritis",
"(",
"e.g",
".",
"rheumatoid",
"arthritis",
",",
"juvenile",
"rheumatoid",
"arthritis",
",",
"psoriatic",
"arthritis",
",",
"systemic",
"lupus",
"erythematosus",
",",
"etc",
".",
")"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0
] |
NCT03014687
|
1:17:chronic_disease
|
Active sinusitis
| 2
|
[
"Active",
"sinusitis"
] |
[
2,
2
] |
NCT02916472
|
26:32:cancer
|
histologically confirmed cancer
| 2
|
[
"histologically",
"confirmed",
"cancer"
] |
[
0,
0,
3
] |
NCT02099058
|
17:49:treatment,78:87:treatment,92:101:treatment
|
Subjects in the combination therapy arms A and D must be eligible to receive erlotinib, or nivolumab per most current prescribing information, or at the discretion of the Investigator
| 2
|
[
"Subjects",
"in",
"the",
"combination",
"therapy",
"arms",
"A",
"and",
"D",
"must",
"be",
"eligible",
"to",
"receive",
"erlotinib",
",",
"or",
"nivolumab",
"per",
"most",
"current",
"prescribing",
"information",
",",
"or",
"at",
"the",
"discretion",
"of",
"the",
"Investigator"
] |
[
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02319369
|
14:23:treatment,42:52:cancer,,109:120:treatment,,191:200:treatment
|
received any therapies intended to treat malignancy within 14 days of first receipt of DS-3032b [except for hydroxyurea, which must be discontinued at least 48 hours (Day -2) prior to study treatment]
| 2
|
[
"received",
"any",
"therapies",
"intended",
"to",
"treat",
"malignancy",
"within",
"14",
"days",
"of",
"first",
"receipt",
"of",
"DS-3032b",
"[",
"except",
"for",
"hydroxyurea",
",",
"which",
"must",
"be",
"discontinued",
"at",
"least",
"48",
"hours",
"(",
"Day",
"-2",
")",
"prior",
"to",
"study",
"treatment",
"]"
] |
[
0,
0,
1,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT03042689
|
,,,104:110:cancer
|
Alkaline phosphatase limit ≤ 2.5 x ULN (≤ 5 x ULN for subjects with liver or bone involvement of their cancer)
| 2
|
[
"Alkaline",
"phosphatase",
"limit",
"≤",
"2.5",
"x",
"ULN",
"(",
"≤",
"5",
"x",
"ULN",
"for",
"subjects",
"with",
"liver",
"or",
"bone",
"involvement",
"of",
"their",
"cancer",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0
] |
NCT02907983
|
1:11:treatment,13:22:treatment,64:84:treatment
|
pregabalin, clonidine, selective estrogen receptor modulators, aromatase inhibitors, tissue selective estrogen complexes
| 2
|
[
"pregabalin",
",",
"clonidine",
",",
"selective",
"estrogen",
"receptor",
"modulators",
",",
"aromatase",
"inhibitors",
",",
"tissue",
"selective",
"estrogen",
"complexes"
] |
[
1,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02004275
|
27:46:chronic_disease
|
No clinically significant pericardial disease
| 2
|
[
"No",
"clinically",
"significant",
"pericardial",
"disease"
] |
[
0,
0,
0,
2,
2
] |
NCT02089607
|
31:54:treatment
|
In such a situation, multiple extra-anatomic bypasses may be necessary
| 2
|
[
"In",
"such",
"a",
"situation",
",",
"multiple",
"extra-anatomic",
"bypasses",
"may",
"be",
"necessary"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02494869
|
1:18:chronic_disease
|
Recurrent syncope
| 2
|
[
"Recurrent",
"syncope"
] |
[
2,
2
] |
NCT02253316
|
1:22:chronic_disease
|
secondary amyloidosis
| 2
|
[
"secondary",
"amyloidosis"
] |
[
2,
2
] |
NCT02442102
|
8:24:chronic_disease
|
Active seizure disorder
| 2
|
[
"Active",
"seizure",
"disorder"
] |
[
0,
2,
2
] |
NCT02138214
|
1:29:chronic_disease,76:94:chronic_disease,98:115:chronic_disease
|
Chronic neurologic condition which affects voice or swallow (for instance, multiple sclerosis or Parkinson disease)
| 2
|
[
"Chronic",
"neurologic",
"condition",
"which",
"affects",
"voice",
"or",
"swallow",
"(",
"for",
"instance",
",",
"multiple",
"sclerosis",
"or",
"Parkinson",
"disease",
")"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0
] |
NCT03160547
|
1:11:chronic_disease
|
Sarcopenia
| 2
|
[
"Sarcopenia"
] |
[
2
] |
NCT02233868
|
1:19:treatment
|
antianginal agents
| 2
|
[
"antianginal",
"agents"
] |
[
1,
1
] |
NCT00432094
|
51:66:chronic_disease
|
Patients must be free of symptoms of uncontrolled cardiac disease
| 2
|
[
"Patients",
"must",
"be",
"free",
"of",
"symptoms",
"of",
"uncontrolled",
"cardiac",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02234934
|
14:30:chronic_disease
|
Uncontrolled seizure disorder
| 2
|
[
"Uncontrolled",
"seizure",
"disorder"
] |
[
0,
2,
2
] |
NCT02329652
|
39:60:chronic_disease
|
subjects should not have a history of autonomic dysreflexia
| 2
|
[
"subjects",
"should",
"not",
"have",
"a",
"history",
"of",
"autonomic",
"dysreflexia"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02019641
|
13:41:chronic_disease
|
Significant hepatic or renal dysfunction
| 2
|
[
"Significant",
"hepatic",
"or",
"renal",
"dysfunction"
] |
[
0,
2,
2,
2,
2
] |
NCT02459769
|
25:31:cancer
|
Have had a diagnosis of cancer
| 2
|
[
"Have",
"had",
"a",
"diagnosis",
"of",
"cancer"
] |
[
0,
0,
0,
0,
0,
3
] |
NCT02547818
|
22:28:chronic_disease
|
Uncontrolled chronic asthma
| 2
|
[
"Uncontrolled",
"chronic",
"asthma"
] |
[
0,
0,
2
] |
NCT02424968
|
30:41:chronic_disease,43:54:chronic_disease,72:83:chronic_disease,94:127:chronic_disease,138:182:chronic_disease
|
Must not be seropositive for HIV 1 and 2, hepatitis B surface antigen, hepatitis C antibody, human T-lymphotropic virus (HTLV) antibody, cytomegalovirus (CMV) immunoglobulin M (IgM), or rapid plasma reagin (RPR) (Treponema)
| 2
|
[
"Must",
"not",
"be",
"seropositive",
"for",
"HIV",
"1",
"and",
"2",
",",
"hepatitis",
"B",
"surface",
"antigen",
",",
"hepatitis",
"C",
"antibody",
",",
"human",
"T-lymphotropic",
"virus",
"(",
"HTLV",
")",
"antibody",
",",
"cytomegalovirus",
"(",
"CMV",
")",
"immunoglobulin",
"M",
"(",
"IgM",
")",
",",
"or",
"rapid",
"plasma",
"reagin",
"(",
"RPR",
")",
"(",
"Treponema",
")"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02308202
|
87:91:chronic_disease
|
We anticipate that participants will be on a wide range of medications prescribed for PTSD
| 2
|
[
"We",
"anticipate",
"that",
"participants",
"will",
"be",
"on",
"a",
"wide",
"range",
"of",
"medications",
"prescribed",
"for",
"PTSD"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02389465
|
22:28:cancer
|
Current diagnosis of cancer
| 2
|
[
"Current",
"diagnosis",
"of",
"cancer"
] |
[
0,
0,
0,
3
] |
NCT00862433
|
12:22:treatment,34:41:treatment,54:78:treatment,80:103:treatment,108:119:treatment
|
No regular medication other than aspirin (other than oral hypoglycemic agents, hormonal contraceptives and medications taken only on an as-needed basis)
| 2
|
[
"No",
"regular",
"medication",
"other",
"than",
"aspirin",
"(",
"other",
"than",
"oral",
"hypoglycemic",
"agents",
",",
"hormonal",
"contraceptives",
"and",
"medications",
"taken",
"only",
"on",
"an",
"as-needed",
"basis",
")"
] |
[
0,
0,
1,
0,
0,
1,
0,
0,
0,
1,
1,
1,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02828618
|
1:9:chronic_disease
|
Dementia or significantly altered mental status that would prohibit the understanding and giving of informed consent
| 2
|
[
"Dementia",
"or",
"significantly",
"altered",
"mental",
"status",
"that",
"would",
"prohibit",
"the",
"understanding",
"and",
"giving",
"of",
"informed",
"consent"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02195232
|
20:64:chronic_disease
|
Known diagnosis of disseminated intravascular coagulation (DIC)
| 2
|
[
"Known",
"diagnosis",
"of",
"disseminated",
"intravascular",
"coagulation",
"(",
"DIC",
")"
] |
[
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02148796
|
21:27:chronic_disease
|
Parental history of asthma
| 2
|
[
"Parental",
"history",
"of",
"asthma"
] |
[
0,
0,
0,
2
] |
NCT02990481
|
1:29:cancer
|
Symptomatic brain metastases
| 2
|
[
"Symptomatic",
"brain",
"metastases"
] |
[
3,
3,
3
] |
NCT03060473
|
4:12:treatment
|
on dialysis
| 2
|
[
"on",
"dialysis"
] |
[
0,
1
] |
NCT02312570
|
1:24:chronic_disease,25:30:chronic_disease,25:31:chronic_disease,164:172:chronic_disease,174:184:chronic_disease,186:195:treatment,197:207:chronic_disease,209:234:chronic_disease,236:242:chronic_disease,247:264:chronic_disease
|
Stage I pressure ulcers Ulcers that are unstageable or of deep tissue morphology that have yet to become an open wound Ulcer not of PU pathophysiology (e.g., pure diabetic, vasculitic, radiation, rheumatoid, collagen vascular disease, venous, or arterial etiology)
| 2
|
[
"Stage",
"I",
"pressure",
"ulcers",
"Ulcers",
"that",
"are",
"unstageable",
"or",
"of",
"deep",
"tissue",
"morphology",
"that",
"have",
"yet",
"to",
"become",
"an",
"open",
"wound",
"Ulcer",
"not",
"of",
"PU",
"pathophysiology",
"(",
"e.g.",
",",
"pure",
"diabetic",
",",
"vasculitic",
",",
"radiation",
",",
"rheumatoid",
",",
"collagen",
"vascular",
"disease",
",",
"venous",
",",
"or",
"arterial",
"etiology",
")"
] |
[
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
1,
0,
2,
0,
2,
2,
2,
0,
2,
0,
0,
2,
2,
0
] |
NCT02343042
|
1:27:chronic_disease,
|
Myocardial infarction (MI) within 3 months prior to C1D1
| 2
|
[
"Myocardial",
"infarction",
"(",
"MI",
")",
"within",
"3",
"months",
"prior",
"to",
"C1D1"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02958462
|
1:25:chronic_disease,31:49:cancer,66:86:cancer,88:118:chronic_disease
|
Marrow failure syndromes with myeloid malignancy predisposition- telomere dysfunction, chromosomal breakage disorders, etc
| 2
|
[
"Marrow",
"failure",
"syndromes",
"with",
"myeloid",
"malignancy",
"predisposition-",
"telomere",
"dysfunction",
",",
"chromosomal",
"breakage",
"disorders",
",",
"etc"
] |
[
2,
2,
2,
0,
3,
3,
0,
3,
3,
0,
2,
2,
2,
0,
0
] |
NCT00737893
|
1:48:chronic_disease
|
Nonarteritic Anterior Ischemic Optic Neuropathy
| 2
|
[
"Nonarteritic",
"Anterior",
"Ischemic",
"Optic",
"Neuropathy"
] |
[
2,
2,
2,
2,
2
] |
NCT03040778
|
21:57:chronic_disease
|
Patients with known hemorrhagic and coagulation disorder
| 2
|
[
"Patients",
"with",
"known",
"hemorrhagic",
"and",
"coagulation",
"disorder"
] |
[
0,
0,
0,
2,
2,
2,
2
] |
NCT01624090
|
38:55:treatment,48:55:treatment,96:108:treatment,
|
Patients may have received localized radiation therapy to non-target lesions provided that the radiotherapy is completed 14 days prior to commencing therapy, and the patient has recovered from any toxicity
| 2
|
[
"Patients",
"may",
"have",
"received",
"localized",
"radiation",
"therapy",
"to",
"non-target",
"lesions",
"provided",
"that",
"the",
"radiotherapy",
"is",
"completed",
"14",
"days",
"prior",
"to",
"commencing",
"therapy",
",",
"and",
"the",
"patient",
"has",
"recovered",
"from",
"any",
"toxicity"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02914834
|
1:29:treatment
|
concomitant physical therapy
| 2
|
[
"concomitant",
"physical",
"therapy"
] |
[
1,
1,
1
] |
NCT02890979
|
32:53:cancer,64:71:chronic_disease,88:126:chronic_disease
|
Subjects with risk factors for esophageal malignancy including Barrett?s esophagus and gastroesophageal reflux disease (GERD)
| 2
|
[
"Subjects",
"with",
"risk",
"factors",
"for",
"esophageal",
"malignancy",
"including",
"Barrett",
"?",
"s",
"esophagus",
"and",
"gastroesophageal",
"reflux",
"disease",
"(",
"GERD",
")"
] |
[
0,
0,
0,
0,
0,
3,
3,
0,
2,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02495389
|
13:32:treatment
|
Patients on current OAB therapy will undergo a two-week drug washout period prior to baseline assessment
| 2
|
[
"Patients",
"on",
"current",
"OAB",
"therapy",
"will",
"undergo",
"a",
"two-week",
"drug",
"washout",
"period",
"prior",
"to",
"baseline",
"assessment"
] |
[
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02585973
|
1:7:treatment,15:38:cancer,40:46:cancer,48:59:cancer,64:75:cancer,,
|
Biopsy proven HNSCC of the oropharynx, larynx, hypopharynx, or oral cavity Stage III-IVB as defined by American Joint Committee on Cancer (AJCC) T0-T4, N0 - N3, M0
| 2
|
[
"Biopsy",
"proven",
"HNSCC",
"of",
"the",
"oropharynx",
",",
"larynx",
",",
"hypopharynx",
",",
"or",
"oral",
"cavity",
"Stage",
"III-IVB",
"as",
"defined",
"by",
"American",
"Joint",
"Committee",
"on",
"Cancer",
"(",
"AJCC",
")",
"T0-T4",
",",
"N0",
"-",
"N3",
",",
"M0"
] |
[
1,
0,
3,
3,
3,
3,
0,
3,
0,
3,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02346526
|
1:10:treatment
|
Treatment should be completed for spinal cord compression
| 2
|
[
"Treatment",
"should",
"be",
"completed",
"for",
"spinal",
"cord",
"compression"
] |
[
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02133885
|
24:32:treatment,,,
|
one of which must be a diuretic (with no changes for a minimum of two weeks prior to screening) that is expected to be maintained without changes for at least 6-9 months
| 2
|
[
"one",
"of",
"which",
"must",
"be",
"a",
"diuretic",
"(",
"with",
"no",
"changes",
"for",
"a",
"minimum",
"of",
"two",
"weeks",
"prior",
"to",
"screening",
")",
"that",
"is",
"expected",
"to",
"be",
"maintained",
"without",
"changes",
"for",
"at",
"least",
"6-9",
"months"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02359253
|
24:30:cancer,32:40:cancer,44:55:cancer
|
First focal unilateral lesion, ischemic or hemorrhagic
| 2
|
[
"First",
"focal",
"unilateral",
"lesion",
",",
"ischemic",
"or",
"hemorrhagic"
] |
[
0,
0,
0,
3,
0,
3,
0,
3
] |
NCT02574910
|
1:10:treatment
|
Treatment with growth hormone at enrollment or during the course of the study
| 2
|
[
"Treatment",
"with",
"growth",
"hormone",
"at",
"enrollment",
"or",
"during",
"the",
"course",
"of",
"the",
"study"
] |
[
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02115295
|
55:81:cancer,83:111:cancer,115:118:cancer
|
For Salvage cohort: Patients with previously treated, relapsed or refractory AML, Acute Biphenotypic Leukemia, or CML in Myeloid Blast Phase are eligible
| 2
|
[
"For",
"Salvage",
"cohort",
":",
"Patients",
"with",
"previously",
"treated",
",",
"relapsed",
"or",
"refractory",
"AML",
",",
"Acute",
"Biphenotypic",
"Leukemia",
",",
"or",
"CML",
"in",
"Myeloid",
"Blast",
"Phase",
"are",
"eligible"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
3,
3,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0
] |
NCT02663596
|
76:86:allergy_name
|
History of any moderate or severe hypersensitivity or allergic reaction to vancomcyin (a history of mild rash followed by uneventful re-exposure and/or red man syndrome is not a contraindication)
| 2
|
[
"History",
"of",
"any",
"moderate",
"or",
"severe",
"hypersensitivity",
"or",
"allergic",
"reaction",
"to",
"vancomcyin",
"(",
"a",
"history",
"of",
"mild",
"rash",
"followed",
"by",
"uneventful",
"re-exposure",
"and/or",
"red",
"man",
"syndrome",
"is",
"not",
"a",
"contraindication",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03066596
|
28:34:chronic_disease
|
Persistent or uncontrolled asthma as per clinic assessment
| 2
|
[
"Persistent",
"or",
"uncontrolled",
"asthma",
"as",
"per",
"clinic",
"assessment"
] |
[
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02503709
|
16:37:treatment,,,,,,,,,,,,786:836:treatment,895:929:treatment
|
The effects of onalespib and AT7519M on the developing human fetus are unknown; for this reason, women of childbearing potential and male patients with partners of childbearing potential must agree to use adequate contraception (hormonal or barrier method of birth control or abstinence) prior to study entry, for the duration of study participation, and for 2 months after completion of study; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately; women of childbearing potential enrolling on study must have a negative pregnancy test within 72 hours of enrollment in order to be eligible; because there is an unknown but potential risk to nursing infants secondary to treatment of the mother with onalespib and AT7519M, breastfeeding should be discontinued while the mother is treated with onalespib and AT7519M
| 2
|
[
"The",
"effects",
"of",
"onalespib",
"and",
"AT7519M",
"on",
"the",
"developing",
"human",
"fetus",
"are",
"unknown",
";",
"for",
"this",
"reason",
",",
"women",
"of",
"childbearing",
"potential",
"and",
"male",
"patients",
"with",
"partners",
"of",
"childbearing",
"potential",
"must",
"agree",
"to",
"use",
"adequate",
"contraception",
"(",
"hormonal",
"or",
"barrier",
"method",
"of",
"birth",
"control",
"or",
"abstinence",
")",
"prior",
"to",
"study",
"entry",
",",
"for",
"the",
"duration",
"of",
"study",
"participation",
",",
"and",
"for",
"2",
"months",
"after",
"completion",
"of",
"study",
";",
"should",
"a",
"woman",
"become",
"pregnant",
"or",
"suspect",
"she",
"is",
"pregnant",
"while",
"she",
"or",
"her",
"partner",
"is",
"participating",
"in",
"this",
"study",
",",
"she",
"should",
"inform",
"her",
"treating",
"physician",
"immediately",
";",
"women",
"of",
"childbearing",
"potential",
"enrolling",
"on",
"study",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"within",
"72",
"hours",
"of",
"enrollment",
"in",
"order",
"to",
"be",
"eligible",
";",
"because",
"there",
"is",
"an",
"unknown",
"but",
"potential",
"risk",
"to",
"nursing",
"infants",
"secondary",
"to",
"treatment",
"of",
"the",
"mother",
"with",
"onalespib",
"and",
"AT7519M",
",",
"breastfeeding",
"should",
"be",
"discontinued",
"while",
"the",
"mother",
"is",
"treated",
"with",
"onalespib",
"and",
"AT7519M"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT02924194
|
28:44:chronic_disease
|
Subjects with a history of seizure disorder
| 2
|
[
"Subjects",
"with",
"a",
"history",
"of",
"seizure",
"disorder"
] |
[
0,
0,
0,
0,
0,
2,
2
] |
NCT01684904
|
1:22:treatment
|
Endoscopic ultrasound
| 2
|
[
"Endoscopic",
"ultrasound"
] |
[
1,
1
] |
NCT01481974
|
1:12:chronic_disease
|
Hepatitis C positive donor liver
| 2
|
[
"Hepatitis",
"C",
"positive",
"donor",
"liver"
] |
[
2,
2,
0,
0,
0
] |
NCT03058952
|
1:32:chronic_disease
|
antisocial personality disorder
| 2
|
[
"antisocial",
"personality",
"disorder"
] |
[
2,
2,
2
] |
NCT02543866
|
,24:33:chronic_disease
|
A history at least one infection due to ESC-R Enterobacteriaceae
| 2
|
[
"A",
"history",
"at",
"least",
"one",
"infection",
"due",
"to",
"ESC-R",
"Enterobacteriaceae"
] |
[
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02865135
|
1:10:chronic_disease
|
mucositis
| 2
|
[
"mucositis"
] |
[
2
] |
NCT02132130
|
1:17:treatment
|
Previous surgery in the study ear
| 2
|
[
"Previous",
"surgery",
"in",
"the",
"study",
"ear"
] |
[
1,
1,
0,
0,
0,
0
] |
NCT03149783
|
1:14:chronic_disease
|
schizophrenia
| 2
|
[
"schizophrenia"
] |
[
2
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.